Theriva Biologics, Inc. - Common stock (TOVX)
CUSIP: 87164U508
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common stock
- Shares outstanding
- 9,600,143
- Total 13F shares
- 491,424
- Share change
- +341,898
- Total reported value
- $677,871
- Price per share
- $1.38
- Number of holders
- 16
- Value change
- +$471,525
- Number of buys
- 14
Quarterly Holders Quick Answers
What is CUSIP 87164U508?
CUSIP 87164U508 identifies TOVX - Theriva Biologics, Inc. - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q4 2024
Recent filing periods for CUSIP 87164U508:
Top shareholders of TOVX - Theriva Biologics, Inc. - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MSD Partners, L.P. |
13F
|
Company |
—
class O/S missing
|
598,411
|
$141,405 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
194,494
|
$45,959 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
189,181
|
$44,703 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
141,168
|
$33,373 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
—
class O/S missing
|
103,710
|
$24,507 | — | 30 Jun 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
—
class O/S missing
|
61,023
|
$14,420 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
48,691
|
$11,506 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
26,477
|
$6,257 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
—
class O/S missing
|
11,047
|
$2,610 | — | 30 Jun 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
—
class O/S missing
|
10,153
|
$2,399 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
—
class O/S missing
|
500
|
$118 | — | 30 Jun 2024 | |
| Iron Horse Wealth Management, LLC |
13F
|
Company |
—
class O/S missing
|
365
|
$86 | — | 30 Jun 2024 | |
| IFP Advisors, Inc |
13F
|
Company |
—
class O/S missing
|
296
|
$70 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
146
|
$34 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
145
|
$34 | — | 30 Jun 2024 | |
| Planning Capital Management Corp |
13F
|
Company |
—
class O/S missing
|
110
|
$26 | — | 30 Jun 2024 | |
| Towne Trust Company, N.A |
13F
|
Company |
—
class O/S missing
|
100
|
$24 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
100
|
$24 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
15
|
$4 | — | 30 Jun 2024 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
—
class O/S missing
|
14
|
$3 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
3
|
$1 | — | 30 Jun 2024 | |
| Francis Tufaro |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
100,000
|
— | — | 15 Dec 2022 |
Institutional Holders of Theriva Biologics, Inc. - Common stock (TOVX) as of Q3 2024
As of 30 Sep 2024,
Theriva Biologics, Inc. - Common stock (TOVX) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
491,424 shares.
The largest 10 holders included
HEIGHTS CAPITAL MANAGEMENT, INC, Anson Funds Management LP, ARMISTICE CAPITAL, LLC, MSD Partners, L.P., MORGAN STANLEY, UBS Group AG, TWO SIGMA INVESTMENTS, LP, HRT FINANCIAL LP, TWO SIGMA SECURITIES, LLC, and BlackRock, Inc..
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q4 2025 Across Filers
Q4 2025 holders
20
Q3 2024 holders
16
Holder diff
-4
| Investor | Q4 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.